Skip to main content
Premium Trial:

Request an Annual Quote

Biocartis' Idylla ctKRAS Mutation Assay

Biocartis has launched is second liquid biopsy product, the the Idylla ctKRAS Mutation Assay, which it developed in partnership with Merck. The assay is designed for sensitive and rapid KRAS mutation testing and requires 1 ml of blood plasma. It enables qualitative detection of 21 KRAS mutations, with less than one minute of hands-on time and a turnaround time of approximately 130 minutes.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.